Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Plant breeding plays a vital role in ensuring global food security by increasing crop yields, improving nutritional quality ...

Nobel laureate David Baker, right, speaks with BioCentury's Simone Fishburn at the Life Science Innovation Northwest ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions-but there is always room for improvement.

Cyclin D1–CDK4/6 phosphorylates GTSE1 in cancer cells, preventing its degradation and sustaining high levels across the cell cycle, which enhances proliferation and correlates with poor prognosis.

Every organ in our body contains a small number of adult stem cells that are specific to its niche. These cells act like a backup system. When needed, they divide to make copies of themselves or ...

Nebius emerges as an AI leader with robust GPU demand, 30% EBIT targets, and ecosystem growth. Click here to read my analysis of NBIS stock.

Learn more about whether Amarin Corporation plc or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Recent IVG breakthroughs bring gene-edited human embryos closer, with CRISPR-Cas9 making heritable gene editing a reality ...

The company’s CRISPR/Cas9 is a revolutionary technology for gene editing which is the process ... As of April 11, 2025, ...

In conclusion, for India to become a global leader in core technologies, we must reform CSIR labs to be more industry-focused ...